ClinicalTrials.gov
ClinicalTrials.gov Menu

Effects on Atherosclerosis Regression of Ezetimibe or Ezetimibe Plus Simvastatin; Evaluated by Fluorodeoxyglucose Positron Emission Tomography (FDG-PET)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00926055
Recruitment Status : Withdrawn
First Posted : June 23, 2009
Last Update Posted : March 18, 2015
Sponsor:
Information provided by:
Korea University

No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
  Recruitment Status : Withdrawn
  Estimated Primary Completion Date : September 2012
  Study Completion Date : No date given